Substrate specificity of human glycinamide ribonucleotide transformylase.

Area of Science:

• Biochemistry
• Enzymology
• Medicinal Chemistry

Background:

• Human glycinamide ribonucleotide transformylase (HGlyRT) is a key enzyme in purine biosynthesis.
• HGlyRT is a validated target for chemotherapeutic drug development.
• Understanding substrate specificity is crucial for designing effective inhibitors.

Purpose of the Study:

• To investigate the nucleotide substrate specificity of human glycinamide ribonucleotide transformylase.
• To characterize the kinetic parameters (V/K values) of various substrate analogs.
• To compare the substrate specificity of the human enzyme with its avian counterpart.

Main Methods:

• Enzyme kinetics assays were performed using purified human HGlyRT.
• A series of glycinamide ribonucleotide analogs were synthesized and tested.
• Inhibition constants (Ki) and Michaelis constants (Km) were determined.

Main Results:

• The enzyme accepted carbocyclic glycinamide ribonucleotide and its phosphonate derivatives with varying efficiencies.
• Several analogs acted as competitive inhibitors, with Ki values significantly higher than the Km for the natural substrate.
• Quantitative differences in substrate acceptance were observed between human and avian HGlyRT.

Conclusions:

• The study elucidates the substrate binding and catalytic mechanism of human HGlyRT.
• The findings provide valuable insights for the rational design of HGlyRT-targeted chemotherapeutic agents.
• Comparative analysis highlights species-specific differences in enzyme activity, relevant for drug development.